A Case of SSRI Induced Irreversible Parkinsonism
- PMID: 25859504
- PMCID: PMC4378786
- DOI: 10.7860/JCDR/2015/11394.5583
A Case of SSRI Induced Irreversible Parkinsonism
Abstract
Serotonin specific reuptake inhibitors (SSRI) are widely used antidepressants for variety of clinical conditions and have found popularity. They are sometimes associated with extrapyramidal side effects including Parkinsonism. We report a case of generalized anxiety disorder on treatment with SSRI (fluoxetine / sertraline) who developed irreversible Parkinsonism. SSRI are known to cause reversible or irreversible motor disturbances through pathophysiological changes in basal ganglion motor system by altering the dopamine receptors postsynaptically. Clinician should keep risk benefit ratio in mind and change of antidepressant of different class may be considered. Case is reported to alert physicians to possibility of motor system damage while treating with SSRI.
Keywords: Drug induced parkinsonism; Epidemiology; Fluoxetine; Sertraline.
References
-
- R Leo. Movement disorders associated with the serotonin selective reuptake inhibitors. J Clin Psychiatry. 1996;57:449–54. - PubMed
-
- S Madhusoodanan, L Alexeenko, R Sanders, R Brenner. Extrapyramidal symptoms associated with antidepressants - a review of literature and analysis of spontaneous reports. Ann Clin Psychiatry. 2010;22:148–56. - PubMed
-
- V Miletic, M Relja. Citalopram-Induced Parkinsonian Syndrome: Case Report. Clin Neuropharmacol. 2011;34:92–93. - PubMed
-
- R Gregory, J White. Can sertraline induce Parkinson’s Disease? Psychosomatics. 2001;42:163–64. - PubMed
-
- F Micheli, M Cersosimo. Drug-induced parkinsonism. Handb Clin Neuro. 2007;84:399–416. - PubMed
Publication types
LinkOut - more resources
Full Text Sources